Transcriptomics Signature of Anti Vaccinia Memory B Cells
2 other identifiers
observational
12
0 countries
N/A
Brief Summary
Analyse the transcriptomic signature of anti vaccinia memory B cells at a short time after vaccination as compared to the signature already established in long-lived memory B cells.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 21, 2015
CompletedFirst Posted
Study publicly available on registry
September 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedSeptember 30, 2015
May 1, 2015
1 year
September 21, 2015
September 29, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
signature of anti vaccinia long-lived memory B cells
12 months
Eligibility Criteria
Healthy donnors vaccinated against smallpox
You may qualify if:
- Healthy donors vaccinated against smallpox
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2015
First Posted
September 22, 2015
Study Start
September 1, 2015
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
September 30, 2015
Record last verified: 2015-05